Author

Kirk D. Miller

Observed names: K. D. Miller, K.D. Miller, Kirk D Miller, Kirk Miller, Kirk D. Miller

Observed institutions: Peace Corps, Centers for Disease Control and Prevention, National Institutes of Health, Kaiser Permanente, University of Washington, Mahidol University, Edward Francis Small Teaching Hospital, University of Oxford, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institutes of Health Clinical Center, Division of Parasitic Diseases and Malaria, Hospital for Tropical Diseases, Science Applications International Corporation (United States)

OpenAlex ID: A5103695591

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1999 · Richard T. Davey, Niranjan Bhat, et al. · Proceedings of the National Academy of Sciences · 849

Visceral abdominal-fat accumulation associated with use of indinavir

1998 · Kirk D Miller, Elizabeth Jones, et al. · The Lancet · 700

Hypoglycaemia in African Children With Severe Malaria

1987 · N.J. White, K. Marsh, et al. · The Lancet · 221

Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases

2000 · Kirk D. Miller, Miriam Cameron, et al. · Annals of Internal Medicine · 211

Severe Cutaneous Reactions among American Travelers Using Pyrimethamine-Sulfadoxine (Fansidar®) for Malaria Prophylaxis

1986 · Kirk D. Miller, Hans O. Lobel, et al. · American Journal of Tropical Medicine and Hygiene · 203

Loa loa Infection in Temporary Residents of Endemic Regions: Recognition of a Hyperresponsive Syndrome with Characteristic Clinical Manifestations

1986 · T. B. Nutman, K. D. Miller, et al. · The Journal of Infectious Diseases · 174

Treatment of Severe Malaria in the United States with a Continuous Infusion of Quinidine Gluconate and Exchange Transfusion

1989 · Kirk D. Miller, Alan E. Greenberg, et al. · New England Journal of Medicine · 169

Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy

1999 · Jack A. Yanovski, Kirk D. Miller, et al. · The Journal of Clinical Endocrinology & Metabolism · 157

PDF

Chloroqine Treatment of Severe Malaria in Children

1988 · Nicholas J. White, Kirk D. Miller, et al. · New England Journal of Medicine · 119

Diethylcarbamazine Prophylaxis for Human Loiasis

1988 · Thomas B. Nutman, Kirk D. Miller, et al. · New England Journal of Medicine · 81

Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient

1999 · Jan M. Orenstein, Mark Feinberg, et al. · AIDS · 70

Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy

2000 · Hiroyu Hatano, Kirk D Miller, et al. · AIDS · 65

A Biphenotypic Human Herpesvirus 8–Associated Primary Bowel Lymphoma

1999 · Michael W. Beaty, Shimareet Kumar, et al. · The American Journal of Surgical Pathology · 60

Pre-Exposure Rabies Immunization with Human Diploid Cell Vaccine: Decreased Antibody Responses in Persons Immunized in Developing Countries

1985 · Kenneth W. Bernard, John W. Sumner, et al. · American Journal of Tropical Medicine and Hygiene · 59

Indinavir‐Associated Interstitial Nephritis and Urothelial Inflammation: Clinical and Cytologic Findings

2002 · Jeffrey B. Kopp, Judith Falloon, et al. · Clinical Infectious Diseases · 55

PDF

Biochemical Evidence of Muscle Injury in African Children with Severe Malaria

1989 · K. D. Miller, N. J. White, et al. · The Journal of Infectious Diseases · 55

In vivo chloroquine-resistant falciparum malaria in western Africa.

1986 · Janet Neequaye, J Coene, et al. · PubMed · 52

Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains

2001 · Yamina Kabrane-Lazizi, Mingdong Zhang, et al. · Journal of General Virology · 45

Guide to Major Clinical Trials of Antiretroviral Therapy in Human Immunodeficiency Virus‐Infected Patients: Protease Inhibitors, Non‐Nucleoside Reverse Transcriptase Inhibitors, and Nucleotide Reverse Transcriptase Inhibitors

1999 · Jorge A. Tavel, Kirk D. Miller, et al. · Clinical Infectious Diseases · 43

In Vivo Chloroquine-resistant Falciparum Malaria in Western Africa

1986 · Janet Neequaye, Jose Coene, et al. · The Lancet · 40

Crystalluria and Urinary Tract Abnormalities Associated With Indinavir

1998 · J.B. Kopp, K.D. Miller, et al. · The Journal of Urology · 38

The Early Kinetics of the Neutralizing Antibody Response after Booster Immunizations with Human Diploid Cell Rabies Vaccine

1986 · Daniel B. Fishbein, Kenneth W. Bernard, et al. · American Journal of Tropical Medicine and Hygiene · 33

Asymptomatic Solitary Pulmonary Nodules Due to Cryptococcus neoformans in Patients Infected with Human Immunodeficiency Virus

1996 · K. D. Miller, J. A. M. Mican, et al. · Clinical Infectious Diseases · 32

PDF

Hepatitis G Virus and Human Immunodeficiency Virus Coinfection: Response to Interferon‐α Therapy

1999 · Daryl T.‐Y. Lau, Kirk D. Miller, et al. · The Journal of Infectious Diseases · 29

Immunotherapy of HIV-Infected Patients with Intermittent Interleukin-2: Effects of Cycle Frequency and Cycle Duration on Degree of CD4+ T-Lymphocyte Expansion

2001 · Kirk D. Miller, Katherine Spooner, et al. · Clinical Immunology · 20

Works count: 39

Citation count: 3,686

H-index: 24

I10-index: 30